echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New antibody neutralizes known variants of the new coronavirus

    New antibody neutralizes known variants of the new coronavirus

    • Last Update: 2022-08-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    【Operation "epidemic" in international war】

    Science and Technology Daily News (Reporter Liu Xia) American scientists have developed a new broadly neutralizing antibody.


    To develop the antibody, one of the study leaders, Dr.


    Alter's team then worked with Duke University scientists to test the effectiveness of these antibodies


    What makes the SP1-77 antibody so broadly neutralizing? Structural studies have shown that SP1-77 is very different from how current antibodies work


    "We hope that this humanized antibody is as effective in neutralizing SARS-CoV-2 in patients as it has been demonstrated in preclinical evaluations,


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.